Loxo Oncology Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for LOXO ONCOLOGY INC, and what generic alternatives to LOXO ONCOLOGY INC drugs are available?
LOXO ONCOLOGY INC has one approved drug.
There are five US patents protecting LOXO ONCOLOGY INC drugs.
There are sixty-six patent family members on LOXO ONCOLOGY INC drugs in thirty-six countries.
Summary for Loxo Oncology Inc
International Patents: | 66 |
US Patents: | 5 |
Tradenames: | 1 |
Ingredients: | 1 |
NDAs: | 1 |
Drugs and US Patents for Loxo Oncology Inc
International Patents for Loxo Oncology Inc Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
South Korea | 102143899 | See Plans and Pricing |
Spain | 2805087 | See Plans and Pricing |
Portugal | 3523301 | See Plans and Pricing |
Japan | 2020536900 | See Plans and Pricing |
Hungary | E051424 | See Plans and Pricing |
Moldova, Republic of | 3523301 | See Plans and Pricing |
Ecuador | SP19032676 | See Plans and Pricing |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.